Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

Abstract Background Chemotherapy-induced peripheral neuropathy (CIPN) is an under-recognized complication of several chemotherapy agents used as part of curative-intent therapy for Hodgkin Lymphoma (HL). In the absence of validated self- or proxy-report measures for children and adolescents, CIPN re...

Full description

Bibliographic Details
Main Authors: Susan K. Parsons, Angie Mae Rodday, Qinglin Pei, Frank G. Keller, Yue Wu, Tara O. Henderson, David Cella, Kara M. Kelly, Sharon M. Castellino
Format: Article
Language:English
Published: SpringerOpen 2023-11-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Chemotherapy-induced peripheral neuropathy
Patient-reported outcomes
Pediatric HL
Online Access:https://doi.org/10.1186/s41687-023-00653-0

Internet

https://doi.org/10.1186/s41687-023-00653-0

Similar Items